Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
The National Cancer Institute and the pharmaceutical maker Allergan Inc. are jointly supporting a trial to determine whether bimatoprost (Latisse) can stimulate regrowth of eyelashes and eyebrows after their loss in chemotherapy. The company told a Food and Drug Administration advisory committee in December 2008 that it would explore that potential use of the drug.
See the original post here:
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
The National Cancer Institute and the pharmaceutical maker Allergan Inc.
See the rest here:
Policy & Practice: Want more health reform news? Subscribe to our podcast – search “Policy & Practice� in the iTunes store
